{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:52:38Z","timestamp":1788173558611,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bloodstream infections (BSIs) are a prominent cause of death and hospitalization among hemodialysis (HD) patients. The emergence of multidrug-resistant organisms (MDRO) is making the management of these infections more challenging. This study describes the clinical characteristics, microbial profiles and antibiotic resistance patterns in patients with BSIs. A retrospective cross-sectional study was conducted at An-Najah National University Hospital from January 2019 to December 2020. Clinical and demographic data regarding BSIs were collected from the hospital information system. Data regarding bacterial isolates and the antimicrobial resistance of BSIs were collected from the microbiology lab. Data were entered and analyzed using version 21 of the Statistical Package for Social Sciences program (IBM-SPSS). 111 BSIs occurred during the study period, with a rate of 1.5 infections per 100 patient-months. These patients had been on HD for the median duration of 747 (360, 1825) days and 62.2% had already had a BSI before the study period. 118 microorganisms were isolated; 99 (83.89%) were gram-positive and 19 (16.1%) were gram-negative. Among the gram-positive isolates, coagulase-negative staphylococci (CoNS) (88, 74.57%) were predominant. As for the gram-negative isolates, the most frequent were both <jats:italic>Stenotrophomonas maltophilia<\/jats:italic> and <jats:italic>Escherichia coli<\/jats:italic>, with five (4.23%) positive cultures each. Among the latter, two were Extended-Spectrum Beta-Lactamase producing (ESBL) (1.69%). The most frequently used empiric antibiotics were a combination of vancomycin and gentamicin (27%), followed by vancomycin alone (24.3%). Regarding gram-positive isolates, vancomycin was the most frequently used and effective antibiotic after cultures, whereas for gram-negative bacteria, it was found to be gentamicin. MDROs were defined as those resistant to at least one agent in three or more antimicrobial categories. 89 (75.4%) isolates were found to be MDRO, 85 (85.85%) gram-positive bacteria and 4 (21%) gram-negative bacteria. When comparing patients according to the type of vascular access, 66 (75%) infections with MDRO were found among patients with central venous catheters (CVCs). However, no statistically significant relationship was found between the type of vascular access and infection with MDRO (<jats:italic>p<\/jats:italic>\u2009=\u20090.523). MDRO cause a remarkably high proportion of BSIs in Palestinian patients. The results of this study support the empiric use of vancomycin and gentamicin to treat these infections. It is vital that health care providers prevent these infections via instituting and adhering to infection control policies in hemodialysis centers and providing proper antibiotic therapy of limited use and duration when necessary to avoid breeding resistance.<\/jats:p>","DOI":"10.1038\/s41598-022-21979-7","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T17:05:00Z","timestamp":1666803900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Patterns of microbial resistance in bloodstream infections of hemodialysis patients: a cross-sectional study from Palestine"],"prefix":"10.1038","volume":"12","author":[{"given":"Shatha A.","family":"AbuTaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasbeeh","family":"Al-Kharraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Belkebir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Abu Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u2019ed H.","family":"Zyoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"21979_CR1","doi-asserted-by":"publisher","unstructured":"Chapter 1: Definition and classification of CKD. Kidney Int. Suppl (2011) 3, 19\u201362. https:\/\/doi.org\/10.1038\/kisup.2012.64 (2013).","DOI":"10.1038\/kisup.2012.64"},{"key":"21979_CR2","unstructured":"United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. https:\/\/adr.usrds.org\/2020 (2021)."},{"key":"21979_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2015.02.324","volume":"66","author":"DM Charytan","year":"2015","unstructured":"Charytan, D. M. et al. Cause of death in patients with diabetic CKD enrolled in the trial to reduce cardiovascular events with aranesp therapy (TREAT). Am. J. Kidney Dis. 66, 429\u2013440. https:\/\/doi.org\/10.1053\/j.ajkd.2015.02.324 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"21979_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12882-018-0849-x","volume":"19","author":"ST Khatib","year":"2018","unstructured":"Khatib, S. T., Hemadneh, M. K., Hasan, S. A., Khazneh, E. & Zyoud, S. H. Quality of life in hemodialysis diabetic patients: A multicenter cross-sectional study from Palestine. BMC Nephrol. 19, 49. https:\/\/doi.org\/10.1186\/s12882-018-0849-x (2018).","journal-title":"BMC Nephrol."},{"key":"21979_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.xkme.2019.04.005","volume":"1","author":"Q Farhan","year":"2019","unstructured":"Farhan, Q., Shemin, D., Gillani, F. S. & D\u2019Agata, E. M. C. Bloodstream infections in hospitalized hemodialysis patients. Kidney Med. 1, 144\u2013146. https:\/\/doi.org\/10.1016\/j.xkme.2019.04.005 (2019).","journal-title":"Kidney Med."},{"key":"21979_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/sdi.12031","volume":"26","author":"SS Lewis","year":"2013","unstructured":"Lewis, S. S. & Sexton, D. J. Metastatic complications of bloodstream infections in hemodialysis patients. Semin. Dial. 26, 47\u201353. https:\/\/doi.org\/10.1111\/sdi.12031 (2013).","journal-title":"Semin. Dial."},{"key":"21979_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12262-020-02095-0","volume":"82","author":"B Borisov","year":"2020","unstructured":"Borisov, B. & Linkova, S. Infectious complications of hemodialysis tunneled catheters\u2014types, diagnosis, and treatment strategies. Indian J. Surg. 82, 460\u2013464. https:\/\/doi.org\/10.1007\/s12262-020-02095-0 (2020).","journal-title":"Indian J. Surg."},{"key":"21979_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/502580","volume":"26","author":"JJ Engemann","year":"2005","unstructured":"Engemann, J. J. et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect. Control Hosp. Epidemiol. 26, 534\u2013539. https:\/\/doi.org\/10.1086\/502580 (2005).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"21979_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1524-4733.2009.00578.x","volume":"13","author":"Z Hong","year":"2010","unstructured":"Hong, Z. et al. Cost-benefit analysis of preventing nosocomial bloodstream infections among hemodialysis patients in Canada in 2004. Value Health 13, 42\u201345. https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00578.x (2010).","journal-title":"Value Health"},{"key":"21979_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1744-9987.2012.01062.x","volume":"16","author":"M Wakasugi","year":"2012","unstructured":"Wakasugi, M., Kawamura, K., Yamamoto, S., Kazama, J. J. & Narita, I. High mortality rate of infectious diseases in dialysis patients: A comparison with the general population in Japan. Ther. Apher. Dial. 16, 226\u2013231. https:\/\/doi.org\/10.1111\/j.1744-9987.2012.01062.x (2012).","journal-title":"Ther. Apher. Dial."},{"key":"21979_CR11","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2215\/CJN.01290308","volume":"3","author":"LS Dalrymple","year":"2008","unstructured":"Dalrymple, L. S. & Go, A. S. Epidemiology of acute infections among patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1487\u20131493. https:\/\/doi.org\/10.2215\/CJN.01290308 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"21979_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1681\/asn.2012070643","volume":"24","author":"P Ravani","year":"2013","unstructured":"Ravani, P. et al. Associations between hemodialysis access type and clinical outcomes: A systematic review. J. Am. Soc. Nephrol. 24, 465\u2013473. https:\/\/doi.org\/10.1681\/asn.2012070643 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"21979_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/1319-2442.225184","volume":"29","author":"SA Hamadneh","year":"2018","unstructured":"Hamadneh, S. A. et al. Vascular access mortality and hospitalization among hemodialysis patients in Palestine. Saudi J. Kidney Dis. Transpl. 29, 120\u2013126. https:\/\/doi.org\/10.4103\/1319-2442.225184 (2018).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"21979_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1525-139X.2007.00379.x","volume":"21","author":"RM Klevens","year":"2008","unstructured":"Klevens, R. M. et al. Dialysis surveillance report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin. Dial. 21, 24\u201328. https:\/\/doi.org\/10.1111\/j.1525-139X.2007.00379.x (2008).","journal-title":"Semin. Dial."},{"key":"21979_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12879-015-0907-y","volume":"15","author":"D Fram","year":"2015","unstructured":"Fram, D. et al. Risk factors for bloodstream infection in patients at a Brazilian hemodialysis center: A case\u2013control study. BMC Infect. Dis. 15, 158. https:\/\/doi.org\/10.1186\/s12879-015-0907-y (2015).","journal-title":"BMC Infect. Dis."},{"key":"21979_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1053\/j.ajkd.2005.05.024","volume":"46","author":"T Lee","year":"2005","unstructured":"Lee, T., Barker, J. & Allon, M. Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes. Am. J. Kidney Dis. 46, 501\u2013508. https:\/\/doi.org\/10.1053\/j.ajkd.2005.05.024 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"21979_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/1319-2442.252907","volume":"30","author":"Z Hamdan","year":"2019","unstructured":"Hamdan, Z., As\u2019ad, N., Sawalmeh, O., Shraim, M. & Kukhon, F. Vascular access types in hemodialysis patients in palestine and factors affecting their distribution: A cross-sectional study. Saudi J. Kidney Dis. Transpl. 30, 166\u2013174 (2019).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"21979_CR18","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.7150\/ijms.6710","volume":"10","author":"M Fysaraki","year":"2013","unstructured":"Fysaraki, M. et al. Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int. J. Med. Sci. 10, 1632\u20131638. https:\/\/doi.org\/10.7150\/ijms.6710 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"21979_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1080\/23744235.2018.1500707","volume":"50","author":"G Dagasso","year":"2018","unstructured":"Dagasso, G. et al. Risk factors associated with bloodstream infections in end-stage renal disease patients: A population-based study. Infect. Dis. (Lond.) 50, 831\u2013836. https:\/\/doi.org\/10.1080\/23744235.2018.1500707 (2018).","journal-title":"Infect. Dis. (Lond.)"},{"key":"21979_CR20","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/cid\/cit546","volume":"57","author":"DB Nguyen","year":"2013","unstructured":"Nguyen, D. B. et al. Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005\u20132011. Clin. Infect. Dis. 57, 1393\u20131400. https:\/\/doi.org\/10.1093\/cid\/cit546 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"21979_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12882-019-1288-z","volume":"20","author":"AM Omari","year":"2019","unstructured":"Omari, A. M. et al. Assessment of nutritional status in the maintenance of haemodialysis patients: A cross-sectional study from Palestine. BMC Nephrol. 20, 92. https:\/\/doi.org\/10.1186\/s12882-019-1288-z (2019).","journal-title":"BMC Nephrol."},{"key":"21979_CR22","first-page":"158","volume":"23","author":"JQ Abumwais","year":"2012","unstructured":"Abumwais, J. Q. Etiology of chronic renal failure in Jenin district, Palestine. Saudi J. Kidney Dis. Transpl. 23, 158\u2013161 (2012).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"21979_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12882-019-1253-x","volume":"20","author":"H Mohamed","year":"2019","unstructured":"Mohamed, H. et al. Determinants and outcomes of access-related blood-stream infections among Irish haemodialysis patients; a cohort study. BMC Nephrol. 20, 68. https:\/\/doi.org\/10.1186\/s12882-019-1253-x (2019).","journal-title":"BMC Nephrol."},{"key":"21979_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-52978-5.00025-2","author":"DB Nguyen","year":"2019","unstructured":"Nguyen, D. B., Arduino, M. J. & Patel, P. R. Hemodialysis-associated infections. Chron. Kidney Dis. Dial. Transpl. https:\/\/doi.org\/10.1016\/B978-0-323-52978-5.00025-2 (2019).","journal-title":"Chron. Kidney Dis. Dial. Transpl."},{"key":"21979_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/1756-0500-7-882","volume":"7","author":"D Fram","year":"2014","unstructured":"Fram, D. et al. Risk factors for morbidity and mortality of bloodstream infection in patients undergoing hemodialysis: A nested case\u2013control study. BMC Res. Notes 7, 882. https:\/\/doi.org\/10.1186\/1756-0500-7-882 (2014).","journal-title":"BMC Res. Notes"},{"key":"21979_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13756-017-0208-x","volume":"6","author":"JA Ayukekbong","year":"2017","unstructured":"Ayukekbong, J. A., Ntemgwa, M. & Atabe, A. N. The threat of antimicrobial resistance in developing countries: Causes and control strategies. Antimicrob. Resist. Infect. Control 6, 47. https:\/\/doi.org\/10.1186\/s13756-017-0208-x (2017).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"21979_CR27","unstructured":"Centers for Disease Control and Prevention. NHSN Dialysis Event Surveillance Protocol. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/8pscdialysiseventcurrent.pdf (2022)."},{"key":"21979_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"21979_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5144\/0256-4947.2019.258","volume":"39","author":"SM Alhazmi","year":"2019","unstructured":"Alhazmi, S. M., Noor, S. O., Alshamrani, M. M. & Farahat, F. M. Bloodstream infection at hemodialysis facilities in Jeddah: A medical record review. Ann. Saudi Med. 39, 258\u2013264. https:\/\/doi.org\/10.5144\/0256-4947.2019.258 (2019).","journal-title":"Ann. Saudi Med."},{"key":"21979_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bjid.2013.10.001","volume":"18","author":"SE Albuquerque","year":"2014","unstructured":"Albuquerque, S. E., Cavalcante Rde, S., Ponce, D. & Fortaleza, C. M. Epidemiology of healthcare-associated infections among patients from a hemodialysis unit in southeastern Brazil. Braz. J. Infect. Dis. 18, 327\u2013330. https:\/\/doi.org\/10.1016\/j.bjid.2013.10.001 (2014).","journal-title":"Braz. J. Infect. Dis."},{"key":"21979_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1053\/j.ajkd.2010.12.013","volume":"57","author":"LN Fitzgibbons","year":"2011","unstructured":"Fitzgibbons, L. N., Puls, D. L., Mackay, K. & Forrest, G. N. Management of gram-positive coccal bacteremia and hemodialysis. Am. J. Kidney Dis. 57, 624\u2013640. https:\/\/doi.org\/10.1053\/j.ajkd.2010.12.013 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"21979_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/qjmed\/hcm040","volume":"100","author":"PC Thomson","year":"2007","unstructured":"Thomson, P. C., Stirling, C. M., Geddes, C. C., Morris, S. T. & Mactier, R. A. Vascular access in haemodialysis patients: A modifiable risk factor for bacteraemia and death. QJM 100, 415\u2013422. https:\/\/doi.org\/10.1093\/qjmed\/hcm040 (2007).","journal-title":"QJM"},{"key":"21979_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5301\/jva.5000610","volume":"18","author":"T Soleymanian","year":"2017","unstructured":"Soleymanian, T., Sheikh, V., Tareh, F., Argani, H. & Ossareh, S. Hemodialysis vascular access and clinical outcomes: An observational multicenter study. J. Vasc. Access. 18, 35\u201342. https:\/\/doi.org\/10.5301\/jva.5000610 (2017).","journal-title":"J. Vasc. Access."},{"key":"21979_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jiph.2016.06.008","volume":"10","author":"F Sahli","year":"2017","unstructured":"Sahli, F., Feidjel, R. & Laalaoui, R. Hemodialysis catheter-related infection: Rates, risk factors and pathogens. J. Infect. Public Health 10, 403\u2013408. https:\/\/doi.org\/10.1016\/j.jiph.2016.06.008 (2017).","journal-title":"J. Infect. Public Health"},{"key":"21979_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.2215\/CJN.13781217","volume":"13","author":"EMC D'Agata","year":"2018","unstructured":"D\u2019Agata, E. M. C. Addressing the problem of multidrug-resistant organisms in dialysis. Clin. J. Am. Soc. Nephrol. 13, 666\u2013668. https:\/\/doi.org\/10.2215\/CJN.13781217 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"21979_CR36","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1017\/ice.2018.237","volume":"39","author":"EMC D'Agata","year":"2018","unstructured":"D\u2019Agata, E. M. C. et al. The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities. Infect. Control Hosp. Epidemiol. 39, 1400\u20131405. https:\/\/doi.org\/10.1017\/ice.2018.237 (2018).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"21979_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel, L. A. et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49, 1\u201345. https:\/\/doi.org\/10.1086\/599376 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"21979_CR38","unstructured":"Haddadin, Y., Annamaraju, P. & Regunath, H. in StatPearls (StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC., 2022)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21979-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21979-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21979-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T17:09:14Z","timestamp":1666804154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21979-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21979"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21979-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18003"}}